Skip to Main content Skip to Navigation

Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation

Abstract : HIV-1 infection is a long-term disease which required a long-life treatment. Besides the standard HAART regiment, HIV gene therapy is a promising alternative strategy which give rise to hope for the better HIV-1 treatment. Protein therapeutics is one another technique that represent high impact results in curing various types of disease. It is already become a significant part of current medical treatments. In this study we first designed aRep, a non-immunoglobulin scaffold protein which target two domains of HIV-1 Pr55Gag, SP1-NC and investigated their roles as an intracellular therapeutic agents. Phage display technology was used for the specific isolation of aRep against a critical C-terminal region of the HIV-1 Pr55Gag precursor from a large and diverse library. The antiviral activity of these two Pr55Gag binders was investigated using different cell systems. Two aRep scaffolds aRep4E3 and aRep9A8 were isolated and characterized. aRep4E3 contains 7 repeat motifs (32 kDa), meanwhile aRep9A8 has 6 repeat motifs (28 kDa). These two scaffold molecules found to be able to display antiviral effects on the late stage of HIV-1 replication, by reducing and delaying the viral progeny production. The difference in the molecular mechanism was observed between these two aRep proteins: aRep4E3 mainly interferes with the packaging of the viral genome, meanwhile aRep9A8 interferes with the proteolytic processing of Gag, and performs as a protease inhibitor to prevent the PR cleavage required for the production of newly infectious mature virus. Interestingly, aRep9A8 is able to survive in the chronical HIV-1 infected cells up to D38 pi with the low level of HIV-1 replication. Taken together, results suggested that aRep, a new type of scaffold protein could serve as a promising alternative agent in protein therapy, not only the HIV-1 infection but also the others pathogens or disorders
Document type :
Complete list of metadatas

Cited literature [133 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Friday, November 3, 2017 - 8:59:45 AM
Last modification on : Wednesday, October 14, 2020 - 4:08:58 AM
Long-term archiving on: : Sunday, February 4, 2018 - 12:31:40 PM


Version validated by the jury (STAR)


  • HAL Id : tel-01628207, version 1



Sudarat Hadpech. Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation. Virology. Université de Lyon; Mahāwitthayālai Chīang Mai, 2017. English. ⟨NNT : 2017LYSE1139⟩. ⟨tel-01628207⟩



Record views


Files downloads